Related Experiment Video
Updated: Jun 17, 2025

08:33
Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research
Published on: January 5, 2024
1.1K
Correction to: Assessing the Long-Term (48-Week) Effectiveness, Safety, and Tolerability of Fremanezumab in Migraine
Piero Barbanti1,2, Gabriella Egeo3, Stefania Proietti4,5
1Headache and Pain Unit, IRCCS San Raffaele, Via Della Pisana 235, 00163, Rome, Italy. piero.barbanti@sanraffaele.it.
Neurology and Therapy
|August 6, 2024
Abstract
No abstract available in PubMed .

